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Laminin receptors for neurite formation
(neural outgrowth/cell surface/basement membrane/cell adhesion)
H. K. KLEINMAN*, R. C. OGLE*, F. B. CANNON*, C. D. LITTLEt, T. M. SWEENEYt,
AND L. LUCKENBILL-EDDS*t
*Laboratory of Developmental Biology and Anomalies, National Institute of Dental Research, National Institutes of Health, Bethesda, MD 20892; and
tDepartment of Anatomy and Cell Biology, University of Virginia, Charlottesville, VA 22903
Communicated by Francis 0. Schmitt, October 6, 1987
ABSTRACT Laminin, a basement membrane glycopro-
tein promotes both cell attachment and neurite outgrowth.
Separate domains on laminin elicit these responses, suggesting
that distinct receptors occur on the surface of cells. NG108-15
neuroblastoma-glioma cells rapidly extend long processes in
the presence of laminin. We report here that '251-labeled
laminin specifically binds to these cells and to three membrane
proteins of 67, 110, and 180 kDa. These proteins were isolated
by affinity chromatography on laminin-Sepharose. The 67-
kDa protein reacted with antibody to the previously charac-
terized receptor for cell attachment to laminin. Antibodies to
the 110-kDa and 180-kDa bands demonstrated that the 110-
kDa protein was found in a variety of epithilial cell lines and
in brain, whereas the 180-kDa protein was neural specific.
Antibodies prepared against the 110-kDa and 180-kDa pro-
teins inhibited neurite outgrowth induced by the neurite-
promoting domain of laminin, whereas antibodies to the
67-kDa laminin receptor had no effect on neurite outgrowth.
We conclude that neuronal cells have multiple cell-surface
laminin receptors and that the 110-kDa and 180-kDa proteins
are involved in neurite formation.
Laminin, a major glycoprotein of basement membranes,
induces a variety of cellular responses, including cell attach-
ment (1-3) and neurite outgrowth (4-9). Laminin is com-
posed of three chains, including the A chain (400 kDa), B1
chain (210 kDa), and B2 chain (200 kDa), which are arranged
in a cross-shaped structure. A large fragment of laminin with
cell-attachment activity has been produced by proteolysis
and localized to the central portion of the cross where the
three chains intersect (10). Subsequently, a synthetic penta-
peptide, Tyr-Ile-Gly-Ser-Arg, was found to exhibit cell at-
tachment activity for a variety of epithelial cells (11). How-
ever, this is not the only biologically active domain in
laminin, since a separate site near the globule at the end of
the long arm of the cross has neurite-promoting activity and
cell attachment activity for certain cells (12, 13). Since these
separate domains elicit distinct activities, it is likely that
different receptors mediate these activities.
Previous studies have shown that there is a specific
laminin receptor on cells (67 kDa) that recognizes the
synthetic peptide Tyr-Ile-Gly-Ser-Arg from a sequence in
the B1 chain (11, 14-16). Evidence that this receptor medi-
ates cell attachment has been shown with antibody to the
receptor, the Tyr-Ile-Gly-Ser-Arg peptide, and proteolytic
fragments of laminin, all of which inhibit the attachment of a
variety of cells to laminin (11). However, Tyr-Ile-Gly-Ser-
Arg peptide and synthetic fragments from the intersection of
the chains lack neurite-promoting activity. The cell-surface
ligand responsible for laminin-mediated neurite outgrowth
has not been identified, but several candidates exist, includ-
ing integrin, sulfatides, and gangliosides (17-20).
Here we have used laminin affinity chromatography to
identify receptors on neuronal cells that might mediate
neurite outgrowth. The NG108-15 neuroblastoma-glioma
cells respond to laminin and extend processes within 1 hr
(21). We find that these cells have three major cell-surface
ligands that bind laminin, including the previously identified
67-kDa laminin adhesion receptor and two additional pro-
teins at 110 kDa and 180 kDa.
METHODS
Cells. NG108-15 neuroblastoma-glioma cells (from M.
Nirenberg, National Institutes of Health) exhibit many neu-
ronal characteristics (22) and extend processes in the pres-
ence of laminin (21).
Undifferentiated stem cells of the PCC4 teratocarcinoma
(23) were grown in high glucose Dulbecco's modified Eagle's
medium (DMEM) without sodium pyruvate (GIBCO) sup-
plemented with 10% fetal bovine serum and antibiotics. To
obtain differentiated cells, cells were plated in 35-mm dishes
at 1.5 x 105 cells per ml and were deprived of fresh medium
for 6 days. The medium was replaced every 3 days until day
23.
Laminin Preparation and Binding to Cells. Laminin was
prepared from the EHS (Englebreth-Holm-Swarm) tumor
(1) and coupled to CNBr-activated Sepharose 4B. Laminin
was iodinated (specific activity, 1 ,uCi/,g; 1 Ci = 37 GBq)
using the chloramine-T procedure (24).
Binding was carried out with cells in suspension according
to Huard et al. (25). Duplicate samples of 200 ,Al of cells (1 x
106) were incubated for 1 hr at room temperature in
DMEM/hypoxanthine/aminopterin/thymidine medium with
1% bovine serum albumin and 20 mM Hepes containing
various concentrations of '25I-labeled laminin ('251-laminin)
with or without a 10-fold excess of unlabeled laminin. After
the cells were centrifuged and washed, the pellet and washes
were counted to determine "bound" and "unbound" lami-
nin.
Affinity Chromatography of Detergent Extracts of Cell
Membranes. Twenty (150-mm diameter) confluent plates of
cells were harvested at 4°C in 0.15 M NaCI/50 mM phos-
phate, pH 7.5, containing 1 mM phenylmelthysulfonyl fluo-
ride, and collected by centrifugation. After homogenization
in a Dounce homogenizer, cell membranes were prepared by
discontinuous sucrose-density cushion centrifugation (16).
The final cell-membrane pellet was extracted with 1.0%
3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfo-
nate) (CHAPS) in 0.01 M Tris HCI (pH 7.4) for 2 hr and then
Abbreviations: '25I-laminin, 125I-labeled laminin; CHAPS, 3-[(3-
cholamidopropyl)dimethylammonio]-1-propanesulfonate; LAM-P,
pepsin-digested laminin.
TPresent address: College of Osteopathic Medicine, Ohio Univer-
sity, Athens, OH 45701.
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circulated after dialysis in column buffer on a laminin-
Sepharose column equilibrated in 0.1% CHAPS/0.01 M
Tris HCl, pH 7.4. The 67-kDa laminin receptor was eluted
with a salt gradient [0.01-1 M NaCl in 0.01 M Tris HCl (pH
7.4) containing 0.1% CHAPS] and then the column was
washed with 0.1 M glycine (pH 2.0). The glycine eluate was
dialyzed against water, lyophilized, and resuspended in 4.0
M guanidine hydrochloride/0.05 M Tris, pH 7.4, containing
0.1% CHAPS. The sample was chromatographed on molec-
ular sieve fast protein liquid chromatography in the same
buffer.
Laminin and Antibody Binding to Cell Homogenates on
Nitrocellulose. Confluent cells were scraped from three
flasks (75 cm2) and were collected by centrifugation. The cell
pellet was extracted for 1 hr at 40C with 0.1% CHAPS in 0.01
M Tris-HCl (pH 7.4) and then centrifuged. Aliquots of the
extract and of a suspension of the pellet were placed in
sample buffer, sonicated, and electrophoresed on a 7.5%
polyacrylamide gel and- either stained with Coomassie bril-
liant blue R250 or transferred to nitrocellulose (26). After
blocking the nitrocellulose with 1% bovine serum albumin, it
was directly incubated with 125I-laminin in 0.05 M Tris-HCl
(pH 7.4) containing 1% bovine serum albumin and 0.05 M
NaCl for 2-18 hr. The filters were then washed seven times
for 5 min each in buffer lacking the 125I-laminin. The
nitrocellulose was air-dried and exposed to film.
For immunoblots, tissues or cells solubilized directly in
sample buffer were sonicated and the proteins in the extract
were electrophoresed and transferred to nitrocellulose as
described above (26).
Antibody Preparation and Immunofluorescence. Antibod-
ies to the 67-kDa laminin receptor were obtained from K.
von der Mark (Max-Planck-Institut, Martinsried, F.R.G.)
and those to the CSAT (fibronectin-laminin) receptor were
from C. Buck (Wistar Institute) and G. Tarone (Univ.
Turin). Antibodies to the 110-kDa and 180-kDa proteins
were prepared in rabbits from material that had been chro-
matographed on a laminin affinity column prior to electro-
phoresis. Several lanes from the gel were pooled, mixed with
RIBI adjuvant (RIBI Immunochem, Hamilton, MT), and
injected into rabbits. The animals received a total of three
injections over 8 weeks.
NG108-15 cells were grown on glass coverslips for 2-3
days, fixed in 3% paraformaldehyde in 0.1 M phosphate
buffer, and incubated with primary antibodies absorbed with
rat and mouse liver powder in solution and diluted 1:10.
Cells were incubated in secondary antibody (goat anti-rabbit
IgG, coupled to fluorescein isothiocyanate; Cappel Labora-
tories, Cochranville, PA) diluted 1:500 in phosphate-
buffered saline (PBS), and mounted in 90% (vol/vol) glyc-
erol in PBS containing 4% n-propylgallate (27). PCC4 cells
were stained with primary antibody diluted 1:20 followed by
goat anti-rabbit antibody coupled with rhodamine (prepared
by C.D.L. and T.M.S.). Stained cultures were examined
with a Leitz microscope with Ploempak filters and photo-
graphed with Tri-X Kodak film.
Antibody Inhibition of Neurite Outgrowth. Cells were
incubated for 45 min at room temperature in DMEM con-
taining 0.02% bovine serum albumin with various amounts of
each antibody and of preimmune sera (all heat-inactivated at
58°C for 30 min). The cells were then centrifuged and washed
in 3 ml of the incubation buffer lacking the antibody before
use. Plates were preincubated with 30 ,g of pepsin-digested
laminin (LAM-P), which had been chromatographed on
heparin Sepharose followed by DEAE-cellulose chromatog-
raphy (G. Sephel, personal communication). This material is
active in neurite outgrowth but not in cell adhesion. After a
2-hr incubation, the cells were photographed. The number of
processes was determined by direct counting. The number of
attached cells in parallel plates was determined.
A*<ffi. >s, lI D
FIG. 1. Ability of laminin to promote process formation. (A) On
plastic, no processes were observed after 1 hr. (B) On a laminin
substrate, processes were observed after 1 hr. (Fixed in 5% forma-
lin; stained with 1% methylene blue.)
RESULTS
Laminin induced the formation of processes in NG108-15
within 1 hr of plating (Fig. 1). Since it was likely that this
effect was due to the interaction of laminin with surface
receptors, we measured the specific binding of '251-laminin
to whole cells. 125I-laminin bound to the cells and part was
displaced by an excess of unlabeled laminin (Table 1).
To identify laminin-binding cell-surface proteins, we pre-
pared cell membranes and extracted them with detergent.
These extracts were chromatographed on a laminin affinity
column. Three major proteins (67, 110, and 180 kDa) bound
to the laminin affinity column (Fig. 2 and 3A). The 67-kDa
laminin receptor bound to laminin and was eluted by NaCl.
It was identified as the previously described laminin recep-
tor, since it stained with authentic anti-receptor antibody
(data not shown) and had a characteristic migration pattern
before and after reduction (Fig. 3B). Proteins at 110 and 180
kDa required stronger eluent-i.e., 0.1 M glycine (pH 2.0)
(Fig. 3A). Thus, the 67-kDa laminin receptor appears to bind
to laminin with a lower avidity than the 110- and 180-kDa
laminin-binding proteins. The 67-kDa laminin receptor with-
out reduction migrated at 55 kDa as reported previously,
while the migration of the 110-kDa laminin-binding protein
was slightly slower and the 180-kDa laminin-binding proteins
migrated slightly faster in the absence of reducing agents
(Fig. 3B). These latter two proteins were further purified by
fast protein liquid chromatography (Fig. 3C).
These three proteins (67, 110, and 180 kDa) bound to
laminin, using a nitrocellulose filter incubated with 1251_
laminin. Cells were extracted with detergent and the solubi-
lized material, as well as an aliquot of the residue (suspended
in sample buffer with sonication), were electrophoresed on a
NaDodSO4/polyacrylamide gel, transferred to nitrocellu-
lose, and incubated with 125I-laminin. Labeled laminin
bound the three major components (67, 110, and 180 kDa)
(Fig. 4). None of these components reacted with anti-CSAT
antibody (data not shown). The 180-kDa band was present in
the soluble fraction of the detergent extract.
Table 1. Binding of 1251-laminin to cells
125-laminin '251-laminin bound Specific
1251-laminin bound, cpm in presence of binding,
added, ng x 10-3 unlabeled laminin cpm x 1 -3
67.5 3.2 ± 0.3 2.0 + 0.4 1.2
135.0 4.5 ± 0.1 0.9 + 0.2 3.5
Binding is expressed as mean ± SEM.















..; K ......V.::5.:L l | .''*'Si






























0 10 20 30 40
Fraction Number
FIG. 2. Laminin affinity chromatography
of NG108-15 cell membranes. The 67-kDa lamn
eluted principally in tube 25, whereas the 110-
were present in the low pH glycine wash. Varn
proteins at 90 and 55 kDa were present in sc
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FIG. 4. Binding of t25I-laminin to NG108-15 cell homogenates
after NaDodSO4/polyacrylamide gel electrophoresis and transfer to
nitrocellulose. Cells were extracted with 0.1% CHAPS for 1 hr and
1.0 aliquots of a suspension of the pellet (lanes 1 and 3) and of the
__c extract (lanes 2 and 4) were electrophoresed on a 5% polyacrylamide
_U ,, gel. The pellet (lane 1) and extract (lane 2) were stained with
z E Coomassie blue and parallel lanes were transferred to nitrocellulose
and incubated with t251-laminin. Three major bands (67, 110, and 180
kDa) bound labeled laminin.
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50 60 70 Table 2), including brain and EHS tumor tissue, as well as in
cultured cells including F9 teratocarcinoma, HT-1080,
of detergent extracts NG108-15 neuroblastoma, and B16 melanoma cells. No
inin adhesion receptor significant reactivity was seen in muscle, cartilage, fat, and
and 180-kDa proteins human skin and 3T3 fibroblasts. Thus, this protein is broadly
iable amounts of other
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We next prepared antibodies to the laminin-binding pro-
teins. The proteins were isolated on a laminin affinity
column, separated by electrophoresis, excised from the gel,
and used to immunize rabbits. The resulting antibodies were
used to assess the occurrence of these proteins in extracts of
various cells and tissues. The 110-kDa laminin-binding pro-
































FIG. 3. (A) NaDodSO4/polyacrylamide gel of 0.1 M glycine (pH
2.0) eluate from laminin affinity column. (B) NaDodSO4/polyacryl-
amide gel of 68-, 110-, and 180-kDa laminin-binding proteins.
Samples were electrophoresed on a 5% polyacrylamide gel in the
presence (+) or absence (-) of reducing agent (dithiothreitol). The
65- and 55-kDa bands are likely degradation products of the 67-kDa
molecule. (C) Purification of the 110- and 180-kDa proteins from the
glycine eluate by fast protein liquid chromatography (FPLC). The
sample from A was chromatographed on a FPLC molecular sieve












FIG. 5. (A) Immunoblot with anti-110-kDa antibody. Brain,
EHS tumor, and NG108-15 cells were placed in sample buffer,
sonicated, and directly electrophoresed on a 7.5% polyacrylamide
gel. Arrow indicates the 110-kDa reactive band. The other lower
molecular mass bands observed, particularly the band at 67 kDa,
also stained with preimmune sera. (B) Immunoblot with anti-180-
kDa antibody. All tissues and procedures were the same as de-
scribed in A. The lower molecular mass bands were also observed
using the preimmune sera from this animal.
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Table 2. Distribution of 110- and 180-kDa laminin-binding proteins in tissues and in cells
Cells Tissue
NG108-15
F9 terato- HT-1080 neuroblastoma- B16 3T3 Skin
carcinoma fibrosarcoma glioma melanoma fibroblasts fibroblasts Muscle Cartilage Brain Fat EHS
110 kDa + + + + + 0 0 0 + 0 +
180 kDa 0 0 + + 0 0 0 0 + 0 0
Homogenates of cell pellets and tissues were evaluated by immunoblot analyses. 0, No reaction; +, stained band.
distributed among epithelial and neural cells. The 180-kDa
laminin-binding protein had a more limited distribution (Fig.
SB; Table 2) and was found only in brain and in cell lines
derived from neuroectoderm, such as NG108-15 and B16
melanoma cells. Thus, the 180-kDa laminin-binding protein
in the cells and tissues that we have examined appears to be
restricted to cells of neural lineage.
Antibody to the 180-kDa protein stained the surfaces of
the cell bodies and processes of NG108-15 cells (Fig. 6A).
Antibody to the 110-kDa protein (Fig. 6B) showed a weaker
pattern of staining. Staining with both antibodies was greater
than that of serum from the preimmune control rabbits (Fig.
6C). The specificity of the 180-kDa protein antibody for
neural cells was confirmed with staining of teratocarcinoma
cells, which contain only 5% neural cells. Only cells with
long neural processes stained with this antibody (Fig. 7A).
These same cells also stained with the neural-specific anti-
body TuJi (28) (data not shown).
A heparin-binding fragment from a pepsin digest of lami-
nin (LAM-P) was isolated. As shown previously, this frag-
ment is the principal neurite-promoting site in laminin (12)
(Fig. 8). Addition of antibody directed toward either the 110-
or the 180-kDa receptor almost completely blocked the
formation of neural processes (Fig. 8). On the other hand,
cells preincubated either with antibody to the 67-kDa adhe-
sion receptor or with preimmune serum formed the same
number of processes on LAM-P substrates as cells without
preincubation (Fig. 8). None of the antibodies reduced cell
attachment to the LAM-P substrate (data not shown). These
data suggest that the 110- and 180-kDa proteins are laminin
receptors that mediate neurite outgrowth.
DISCUSSION
Laminin is a large multifunctional molecule that affects the
behavior of many cells, including the attachment of cells to
a substrate and induction of morphological changes and cell
differentiation (3). Separate domains have been demon-
strated for cell adhesion and for neurite outgrowth (12);
therefore, it is not unexpected that there are multiple cellular
FIG. 6. Immunofluorescence of NG108-15 cells showing surface
staining with antibody to 180-kDa protein (A), 110-kDa protein (B)
on cell bodies and processes (arrows). No staining is seen with
preimmune serum (C). (Bar = 10 ,um.)
receptors for laminin. We demonstrate here that neuro-
blastoma-glioma cells contain two additional laminin-
binding proteins (110 and 180 kDa). We have also isolated
these proteins from a human neuroblastoma cell line, LAN
(unpublished data). These proteins are distinct from the
previously described laminin receptor (67 kDa), which is
present on many cells (14-16) and is involved in cell adhe-
sion to laminin through the Tyr-Ile-Gly-Ser-Arg site on the
B1 chain of laminin (11). The two proteins described here
have a greater affinity for laminin because they require
stronger elution conditions from the laminin affinity column
than the 67-kDa receptor. Recently a 120-kDa laminin-
binding protein from NG108-15 cells has been identified and
is likely related to our 110-kDa protein (29).
The 67, 110, and 180-kDa laminin receptors all have a
stronger affinity for laminin than integrin (CSAT). Binding of
laminin to integrin cannot be readily demonstrated by affin-
ity chromatography or by immunoblotting (17, 30). In addi-
tion, antibody to the p component of integrin does not react
with either the 110- or 180-kDa band (unpublished data). We
also do not find the 110- or 180-kDa protein on fibroblasts.
Thus, the laminin-binding proteins described here are not
likely to be directly related to integrin, although antibodies
to integrin can block laminin-mediated neurite outgrowth
(31). Possibly the anti-integrin antibody inhibits neural pro-
cess formation for steric reasons by reacting with other
components of the receptor coupled in the membrane. Also,
RGDS has been shown to be the interactive site on fibro-
FIG. 7. Immunofluorescence of neuron-like cells in differenti-
ated PCC4 teratocarcinoma cells stained with antibody to 180-kDa
protein. (A) Antibody to the 180-kDa protein. (B) Cells viewed in
phase contrast. Cells with long thin processes stain with this
antibody, whereas flat epithelial-like cells are unstained (arrows).
The neuronal-like cells also stained with TuJi antibody, a neural-
specific 83-tubulin antibody.
'7f"
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FIG. 8. Effect of antibodies on inhibiting NG108-15 process
outgrowth mediated by a laminin fragment. Preimmune serum,
anti-67-kDa, 110-kDa, and 180-kDa antibodies, each at a final
concentration of 30%, were preincubated with NG108-15 cells as
described.
nectin that binds to integrin (32), yet RGDS does not
promote neurite outgrowth and does not inhibit laminin-
mediated neurite outgrowth (L.L.-E., unpublished data).
Thus, this site (RGDS) on fibronectin may not have a direct
effect on neurite formation.
Our evidence suggests that the 180-kDa receptor is spe-
cific to the nervous system and that the 110-kDa receptor is
common to many epithelial and neural cells. Both molecules
are involved in neurite outgrowth since their respective
antibodies can block process formation. Based on their
different cellular distribution, it is likely that the 110- and
180-kDa proteins are not part of a receptor complex similar
to that observed for integrin (17, 18, 30), but rather exist as
separate receptor(s). It is not clear whether the receptors
both bind to the same site on laminin or if two separate sites
exist that "cooperate" to form processes.
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